From developments in cell culture media to enhancing the potency of monoclonal antibodies – check out our free eBook.

AstraZeneca’s FluMist is the first flu vaccine to be approved for self-administration.

The analytical complexities that come with oligonucleotide manufacturing are difficult, but not impossible.

Here’s how an mRNA-based approach can overcome the development challenges of designing protein therapeutics.

We look at three recent studies that demonstrate the versatility of hot melt extrusion for developing patient-centric dosage forms.

Supply chain lessons have been learned since COVID-19, so why are we seeing so many drug shortages?

Researchers use AI to reprogram glioblastoma cancer cells

Regulators want more pediatric formulations. Companies often turn to liquids, but there are specific challenges that need to be considered.

With so many CDMOs to choose from, what should you consider before picking your partner? Here’s some advice from Vetter.

Ever wondered what the distant future of pharma and healthcare looks like? A group of industry experts offer their sage predictions.